Key result
Cardiopulmonary failure in patients with Takotsubo cardiomyopathy was associated with significantly increased 5-year all-cause mortality (41.0% vs 21.4%, RR 1.5) compared to those without cardiopulmonary failure.
Why the study?
Does cardiopulmonary failure increase short- and long-term mortality in patients with Takotsubo cardiomyopathy?
Population
114 consecutive patients diagnosed with Takotsubo cardiomyopathy according to Mayo Clinic Criteria, treated…
Comparison
Presence of cardiopulmonary failure vs Absence of cardiopulmonary failure
Design
Cohort
Follow-up
mean 1529 ± 1121 days
Authors
Loading...
May support risk stratification in Takotsubo cardiomyopathy; leaves open whether interventions improve survival.
Observational (n=114)
No
Does cardiopulmonary failure increase short- and long-term mortality in patients with Takotsubo cardiomyopathy?
Relative Risk: 1.5 (95% CI 0.99–2.23)
Absolute Event Rate: 41% vs 21.4%
p-value: p=<0.05
Cardiopulmonary failure is a frequent complication in Takotsubo cardiomyopathy (38.6%) and is associated with significantly increased short- and long-term mortality.
El‐Battrawy et al. (2017) conducted an observational in Takotsubo cardiomyopathy (n=114). Cardiopulmonary failure vs. Absence of cardiopulmonary failure was evaluated on 5-year all-cause mortality (RR 1.5, 95% CI 0.99-2.23, p=<0.05). Cardiopulmonary failure in patients with Takotsubo cardiomyopathy was associated with significantly increased 5-year all-cause mortality (41.0% vs 21.4%, RR 1.5) compared to those without cardiopulmonary failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: